Headline News about Roche Holding AG Basel American Depositary Shares
![](https://cdn.benzinga.com/files/images/story/2023/09/07/alny.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/01/roche.png?width=1200&height=800&fit=crop)
Roche's Approved Lung Cancer Drug Beats Chemo In Rare Type Of Lung Cancer
September 01, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/08/30/cancer-image_by_pdpics_from_pixabay-.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/04/pte_biotech_1600-1024x576.png)
![](https://cdn.benzinga.com/files/images/story/2023/08/23/roche_0.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://g.foolcdn.com/editorial/images/740239/healthcare.jpg)
![](https://www.investors.com/wp-content/uploads/2017/11/Stock-Roche-02-company.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/08/23/roche.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/21/regn_0.png?width=1200&height=800&fit=crop)
Regeneron's Crucial Eylea HD Approval: A Shield Against Potential Biosimilar Competition?
August 21, 2023
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2023/08/21/exel.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/744754/healthcare.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/08/16/aapharma_4.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2021/03/Stock-DrugsPills-14-adobe.jpg)
![](https://investorplace.com/wp-content/uploads/2023/08/ttoo1600-1.png)
![](https://g.foolcdn.com/editorial/images/741720/a-person-delivering-a-presentation-getty.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/08/03/arav.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/28/jnj.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/26/saxenda-_liraglutida.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/24/tsla.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/24/alny.png?width=1200&height=800&fit=crop)
![](https://images.pexels.com/photos/5716001/pexels-photo-5716001.jpeg?auto=compress&cs=tinysrgb&dpr=1&w=500)
![](https://g.foolcdn.com/editorial/images/740003/growth-curve.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/07/14/hollywood_sign-wikimedia.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/07/14/roiv.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2017/11/Stock-Roche-02-company.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/07/13/roche.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/28/bwv.png?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.